Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care

Medical Care Research and Review : MCRR
Paul A FishmanMichael J Goodman

Abstract

Empirical studies of health care cost, productivity, and output have focused primarily on intermediate goods and services. Consumers are ultimately interested in final goods such as improved health or health-related quality of life, but health services research continues to address whether health services financing and delivery are structured in ways to maximize production of intermediate goods, regardless of the link between these services and final outcomes. Increasing rates of growth of health care cost and dissatisfaction with the quality of U.S. health care force us to reexamine how productivity and cost are analyzed so that research properly informs policy and practice. The authors examine recent changes in the U.S. health care sector that suggest the need to revise how health services research approaches analyses of cost, production, and output; consider alternative notions of final goods; and review the availability and quality of data necessary to conduct this research.

References

Mar 14, 1996·The New England Journal of Medicine·M M KitahataE H Wagner
Dec 1, 1995·The Joint Commission Journal on Quality Improvement·P S RomanoD Campa
Dec 12, 1997·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·K A Phillips, H S Luft
Nov 25, 1998·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·U E Reinhardt
Dec 10, 1990·Home Health Care Services Quarterly·R R McAbeeB Horn
Aug 8, 1986·Journal of Health Economics·G A Jensen, M A Morrisey
Jun 15, 1999·JAMA : the Journal of the American Medical Association·T P HoferW G Manning
Jun 15, 1999·JAMA : the Journal of the American Medical Association·A B Bindman
Jan 29, 2000·Health Affairs·J ChristiansonP Drury
Sep 18, 2001·Health Affairs·D M Cutler, M McClellan
Jan 16, 2002·The Milbank Quarterly·R E GlasgowE H Wagner
Jan 31, 2002·Health Affairs·D M Cutler
Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Mar 20, 2002·Health Affairs·Alan LylesPatricia Drury
Apr 12, 2002·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Tim McAfeeJennifer McClure
Jul 16, 2002·Health Affairs·Robert H Miller, Harold S Luft
Sep 24, 2002·JAMA : the Journal of the American Medical Association·Danny McCormickDavid H Bor
Feb 3, 2004·Pediatrics·Aaron E Carroll, Dimitri A Christakis

❮ Previous
Next ❯

Citations

Feb 8, 2005·BMJ : British Medical Journal·Rhiannon Tudor Edwards
Feb 18, 2011·Heart & Lung : the Journal of Critical Care·Rebecca L DekkerDebra K Moser
Dec 24, 2010·Journal of Psychosocial Nursing and Mental Health Services·Deborah EdmonsonLarry Hughes
Nov 13, 2007·The Nursing Clinics of North America·Margaret C Wilmoth
Jan 5, 2014·Nursing Forum·Kari HickeyEmily Schlenker
Apr 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Mohsen Asadi-Lari, David Gray
Sep 12, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Pennifer EricksonLaurie Burke
Aug 22, 2013·Journal of the National Cancer Institute. Monographs·Maureen C O'Keeffe-RosettiRamzi Salloum
Jan 15, 2009·Scandinavian Journal of Public Health·Anne KonuReijo Sund
Feb 13, 2010·Medical Care Research and Review : MCRR·Kitty S ChanJonathan P Weiner
Jul 10, 2019·International Journal of Health Care Quality Assurance·George A HeckmanPaul Stolee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.